P.Y. Scarabin
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 5
- Platelet Disorders and Treatments 2
- Internal Medicine top 10%
-
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Blood properties and coagulation 3
-
- Retinal Diseases and Treatments 3
-
- Retinal Imaging and Analysis 3
-
- Adipokines, Inflammation, and Metabolic Diseases 2
- Co-authors
- M SamamaDominique ArveilerGiang Huong NguyenMats RånbyL. BaraViviane NicaudA. EvansAdriano Henney
- Partner nations
- FranceUnited KingdomAustralia
In The Last Decade
P.Y. Scarabin
19 papers receiving 411 citations
Peers
Comparison fields: 5 of 56
- Hematology 225
- Internal Medicine 44
- Cancer Research 144
- Cardiology and Cardiovascular Medicine 133
- Endocrinology, Diabetes and Metabolism 67
Countries citing papers authored by P.Y. Scarabin
This map shows the geographic impact of P.Y. Scarabin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.Y. Scarabin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.Y. Scarabin more than expected).
Fields of papers citing papers by P.Y. Scarabin
This network shows the impact of papers produced by P.Y. Scarabin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.Y. Scarabin. The network helps show where P.Y. Scarabin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P.Y. Scarabin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 1 | |
| 2 | 2009 | 1 | |
| 3 | Association between TAFI antigen and Ala l47Thr polymorphism of the TAFI gene and the angina pectoris incidence | 2003 | 47 |
| 4 | 2002 | 3 | |
| 5 | 2000 | 12 | |
| 6 | 1995 | 200 | |
| 7 | 1991 | 1 | |
| 8 | 1990 | 3 | |
| 9 | 1990 | 2 | |
| 10 | 1989 | 77 | |
| 11 | 1988 | 7 | |
| 12 | Reliability of a single beta-thromboglobulin measurement in a diabetic population: importance of PGE1 in anticoagulant mixture. Damad Study Group. | 1987 | 1 |
| 13 | 1987 | 6 | |
| 14 | 1987 | 1 | |
| 15 | 1985 | 2 | |
| 16 | 1981 | 7 | |
| 17 | 1980 | 12 | |
| 18 | 1980 | 43 | |
| 19 | 1979 | 7 |
About P.Y. Scarabin
P.Y. Scarabin is a scholar working on Hematology, Ophthalmology, Endocrinology, Diabetes and Metabolism, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 433 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Blood properties and coagulation (3 papers), Retinal Diseases and Treatments (3 papers), Retinal Imaging and Analysis (3 papers), Platelet Disorders and Treatments (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Hematology (225 citations), Internal Medicine (44 citations), Cancer Research (144 citations), Cardiology and Cardiovascular Medicine (133 citations) and Endocrinology, Diabetes and Metabolism (67 citations). P.Y. Scarabin has collaborated with scholars based in France, United Kingdom and Australia. Frequent co-authors include M Samama, Dominique Arveiler, Giang Huong Nguyen, Mats Rånby, L. Bara, Viviane Nicaud, A. Evans, Adriano Henney, Sally J. Dawson and G. Luc. Their work appears in journals such as Thrombosis and Haemostasis, Thrombosis Research, Maturitas, Journal of Human Hypertension and European Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.